Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species

被引:35
作者
Doran, Derek E. [1 ]
Weiss, Daiana [1 ]
Zhang, Yong [1 ]
Griendling, Kathy K. [1 ]
Taylor, W. Robert [1 ]
机构
[1] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA
关键词
atherosclerosis; angiotensin II; angiotensin II receptor antagonists; oxidative stress; vascular biology;
D O I
10.1016/j.atherosclerosis.2006.11.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin 11 receptor blockade has been shown to inhibit atherosclerosis in several different animal models. We sought to determine if this effect was the result of blood pressure reduction per se or a result of the anti-inflammatory effects of receptor blockade. ApoE-deficient mice were fed a high fat diet and treated with either an angiotensin II receptor antagonist, candesartan (0.5 mg/kg/day, SC) or a calcium channel blocker, amlodipine (7.5 mg/kg/day, mixed with food). Atherosclerotic lesion area, aortic inflammatory gene expression as well as aortic H2O2 and superoxide production were assayed. We found that candesartan but not amlodipine treatment dramatically attenuated the development of atherosclerosis despite a similar reduction in blood pressure. Similarly, candesartan treatment inhibited aortic expression of inflammatory genes and production of reactive oxygen species, effects not seen with amlodipine. These data demonstrate that angiotensin II receptor blockade inhibits atherosclerosis by reducing vascular oxidative stress and inflammatory gene production independent of blood pressure reduction. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 56 条
[11]   DISSOCIATION BETWEEN THE ANTIATHEROSCLEROTIC EFFECT OF TRANDOLAPRIL AND SUPPRESSION OF SERUM AND AORTIC ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].
CHOBANIAN, AV ;
HOPE, S ;
BRECHER, P .
HYPERTENSION, 1995, 25 (06) :1306-1310
[12]   Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation [J].
da Cunha, V ;
Tham, DM ;
Martin-McNulty, B ;
Deng, G ;
Ho, JJ ;
Wilson, DW ;
Rutledge, JC ;
Vergona, R ;
Sullivan, ME ;
Wang, YX .
ATHEROSCLEROSIS, 2005, 178 (01) :9-17
[13]   Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice [J].
Daugherty, A ;
Cassis, L .
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS, 1999, 892 :108-118
[14]   Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice [J].
Daugherty, A ;
Manning, MW ;
Cassis, LA .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1605-1612
[15]  
Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205
[16]   Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis [J].
Dzau, VJ .
HYPERTENSION, 2001, 37 (04) :1047-1052
[17]   An in vitro study of the peroxyl and hydroxyl radical scavenging capacity of the calcium antagonist amlodipine [J].
Franzoni, F ;
Santoro, G ;
Regoli, F ;
Plantinga, Y ;
Femia, FR ;
Carpi, A ;
Galetta, F .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (08) :423-426
[18]   The pathophysiology of hypertension - The importance of angiotensin II in cardiovascular remodeling [J].
Gibbons, GH .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (11) :177S-181S
[19]   ANGIOTENSIN-II STIMULATES NADH AND NADPH OXIDASE ACTIVITY IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
GRIENDLING, KK ;
MINIERI, CA ;
OLLERENSHAW, JD ;
ALEXANDER, RW .
CIRCULATION RESEARCH, 1994, 74 (06) :1141-1148
[20]  
GRIENDLING KK, 1993, SEMIN NEPHROL, V13, P558